Inventor · disambiguated record
David Chih-Kuang Chou
Also filed as: CHOU David Chih-Kuang
6 granted patents·8 pending applications·4 citations·filing 2016–2024
73Inventor score
Technology areasA61K
Files withLUMOSA THERAPEUTICS CO LTD14
Top patents by PatentIndex Score
14 records- 0190US11707501B2Pharmaceutical composition comprising thrombolytic peptide-tetrahydroisoquinoline conjugateLUMOSA THERAPEUTICS CO LTD·Filed 2022·Granted Jul 25, 2023·2 cites·14 claims
- 0287US11338008B2Pharmaceutical composition comprising thrombolytic peptide-tetrahydroisoquinoline conjugateLUMOSA THERAPEUTICS CO LTD·Filed 2020·Granted May 24, 2022·2 cites·6 claims
- 0379US12059448B2Pharmaceutical composition comprising thrombolytic peptide-tetrahydroisoquinoline conjugateLUMOSA THERAPEUTICS CO LTD·Filed 2023·Granted Aug 13, 2024·0 cites·15 claims
- 0479US2025186534A1Pharmaceutical composition comprising thrombolytic peptide-tetrahydroisoquinoline conjugateLUMOSA THERAPEUTICS CO LTD·Filed 2024·Application pending·0 cites
- 0565US11241424B2Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine esterLUMOSA THERAPEUTICS CO LTD·Filed 2019·Granted Feb 8, 2022·0 cites·37 claims
- 0660US11234974B2Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine esterLUMOSA THERAPEUTICS CO LTD·Filed 2018·Granted Feb 1, 2022·0 cites·16 claims
- 0760US2024016794A1Method for treating acute ischemic strokeLUMOSA THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0859US2022071987A1Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine esterLUMOSA THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0957US2022362226A1Compositions and methods for treating pruritusLUMOSA THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1051US2019298702A1Compositions and methods for treating pruritusLUMOSA THERAPEUTICS CO LTD·Filed 2019·Application pending·0 cites
- 1150US2021330667A1Topical composition of nalbuphine and method for treating pruritus condition, pain, or inflammatory condition by using the sameLUMOSA THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1249US10183018B2Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine esterLUMOSA THERAPEUTICS CO LTD·Filed 2016·Granted Jan 22, 2019·0 cites·6 claims
- 1348US2020179373A1Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine esterLUMOSA THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 1443US2020030318A1Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine esterLUMOSA THERAPEUTICS CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Chih-Kuang Chou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →